Trial Profile
Prospective registry of patients undergoing Percutaneous Coronary Intervention administered with Bivalirudin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms EUROVISION
- 26 Nov 2015 New trial record